December 1, 2021

Former Congresswoman Susan Brooks and Former FDA Commissioner Peggy Hamburg Join the Bipartisan Commission on Biodefense

Contact:   Steve Aaron
SRA Communications
(717) 554-8614 



Brooks and Hamburg Bring Additional Bipartisan Biodefense Expertise to the Commission


WASHINGTON, D.C. (Dec. 1, 2021) – The Bipartisan Commission on Biodefense is delighted to welcome two new Commissioners: former U.S. Representative Susan W. Brooks and former Commissioner of the Food and Drug Administration Margaret A. (Peggy) Hamburg. Congresswoman Brooks, a Republican, represented the 5th District of Indiana from 2013-2021. Commissioner Hamburg, a Democrat, served as the twenty-first commissioner of the U.S. Food and Drug Administration from 2009-2015.

“We are very pleased to welcome Congresswoman Brooks and Commissioner Hamburg, whose wealth of expertise will enhance the work of this Commission,” said former Senator Joe Lieberman, Commission Co-Chair. “During her time in Congress, Susan Brooks ensured that many of our recommendations from our original National Blueprint for Biodefense were included in the Pandemic All-Hazards Preparedness and Advancing Innovation Act. Peggy Hamburg has also spent considerable time addressing biological threats, during her time as FDA Commissioner and previously as the Assistant Secretary for Planning and Evaluation, when she served under one of our founding Commissioners, former Secretary of Health and Human Services Donna Shalala. We look forward to their contributions to our important work.”

Congresswoman Brooks was named the inaugural Congressional Biosecurity Champion by the Alliance for Biosecurity for her work on improving the Nation’s readiness for biological threats like Ebola and anthrax. Before joining the U.S. House of Representatives, Ms. Brooks served as Senior Vice President and General Counsel for Ivy Tech Community College from 2007-2012 where she focused on workforce development strategies aimed at enhancing job training and placement for thousands of Hoosier residents. In 2001, President George W. Bush appointed Brooks as U.S. Attorney for the Southern District of Indiana. She received bipartisan acclaim for efforts to battle mortgage fraud, gun violence, drug trafficking, gang activity, child exploitation, and identity theft.

Margaret (Peggy) Hamburg, MD, recently retired as Foreign Secretary for the National Academy of Medicine and finished terms as President and Board Chair of the American Association for the Advancement of Science. She is an internationally recognized leader in public health, medicine, and science. At the FDA, Commissioner Hamburg was known for advancing regulatory science, modernizing regulatory pathways, and globalizing the agency. Before this, she was founding Vice President for Biological Programs at the Nuclear Threat Initiative, a foundation dedicated to reducing nuclear, chemical, and biological threats. Other past positions include Commissioner of Health for New York City, and Assistant Director of the National Institute of Allergy and Infectious Diseases.

“Susan and Peggy remind us that the word ‘bipartisan’ in our Commission’s name is not just an afterthought,” said former Secretary of Homeland Security, Governor Tom Ridge. “The bipartisan work that goes into developing our recommendations serves an important purpose. It underscores that preparing for a biological incident is not a Republican or a Democrat issue – it is a matter of national security that should concern all Americans regardless of party affiliation. Susan and Peggy each have long and distinguished track records of working across party lines to help make our country a safer place. We are thrilled to have them on board.”


About the Bipartisan Commission on Biodefense

The Bipartisan Commission on Biodefense was established in 2014 to conduct a comprehensive assessment of the state of U.S. biodefense efforts, and to issue recommendations to foster change. The Commission’s 2015 report, National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts, identified capability gaps and recommended changes to U.S. policy and law to strengthen national biodefense while optimizing resource investments. In its 2021 report, Biodefense in Crisis: Immediate Action Needed to Address National Vulnerabilities, the Commission described the extent to which the federal government has implemented the Commission’s recommendations. Other Commission publications have addressed critical needs for an Apollo Program for Biodefense; national biodetection; biodefense of critical infrastructure; diagnostics; State, Local, Tribal and Territorial response capabilities; agrodefense; and biodefense budgeting. In September 2018, the White House released the National Biodefense Strategy, a top recommendation from the Blueprint. The Commission continues to address biodefense challenges and urge reform. Former Senator Joe Lieberman and Governor Tom Ridge co-chair the Commission. Hudson Institute is the Commission’s fiscal sponsor.